Sudbury, MA, United States of America

Timothy R Wagenaar

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Sanofi. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy R Wagenaar. Retrieved from https://idiyas.com/inventor/timothy-r-wagenaar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Timothy R Wagenaar

Introduction

Timothy R Wagenaar is an accomplished inventor based in Sudbury, MA (US). He has made significant contributions to the field of therapeutic RNAs, particularly in the treatment of solid tumor cancers. His innovative work has led to the development of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Timothy holds a patent for Therapeutic RNA, which focuses on the use of therapeutic RNAs for the treatment of solid tumor cancers. This patent represents a crucial step forward in cancer treatment, offering new hope for patients battling this challenging disease. He has 1 patent to his name, reflecting his commitment to innovation in the medical field.

Career Highlights

Timothy is currently employed at Sanofi, a global biopharmaceutical company known for its focus on research and development in healthcare. His role at Sanofi allows him to collaborate with leading experts in the field and contribute to groundbreaking research that can change lives.

Collaborations

Throughout his career, Timothy has worked alongside notable colleagues such as Friederike Gieseke and Ugur Sahin. These collaborations have enriched his research and expanded the impact of his work in the field of therapeutic RNAs.

Conclusion

Timothy R Wagenaar is a pioneering inventor whose work in therapeutic RNAs is making a significant impact in the fight against solid tumor cancers. His dedication to innovation and collaboration continues to drive advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…